Similar Survival, Less Toxicity With Decitabine vs Chemo in AML Similar Survival, Less Toxicity With Decitabine vs Chemo in AML

For patients with acute myeloid leukemia, treatment with decitabine prior to stem cell transplantation had similar overall survival and much less toxicity compared with intensive chemotherapy.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news